PAG
LRMR icon

Private Advisor Group’s Larimar Therapeutics LRMR Stock Holding History

Private Advisor Group’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-121
Closed -$2K – 2647
2020
Q2 		$2K Buy
+121
New +$1.41K ﹤0.01% 3578
2019
Q1 		– Sell
-961
Closed -$57K – 1576
2018
Q4 		$57K Sell
961
-500
-34% -$49.4K ﹤0.01% 1317
2018
Q3 		$205K Buy
1,461
+128
+10% +$15.5K ﹤0.01% 1437
2018
Q2 		$153K Buy
+1,333
New +$113K ﹤0.01% 1230
2018
Q1 		– Sell
-1,333
Closed -$87K – 1283
2017
Q4 		$87K Buy
1,333
+299
+29% +$13.5K ﹤0.01% 1146
2017
Q3 		$42K Buy
1,034
+167
+19% +$6.95K ﹤0.01% 1443
2017
Q2 		$35K Hold
867
– – ﹤0.01% 1361
2017
Q1 		$52K Buy
+867
New +$43K ﹤0.01% 1387

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return

Private Advisor Group's LRMR Position: Q3 2020 in Review

Private Advisor Group sold out of Larimar Therapeutics (LRMR) in Q3 2020, closing a stake of 121 shares — an estimated $2K sold.

Private Advisor Group first reported a position in LRMR in Q1 2017 and held it in 8 quarters. The position peaked at $205K in Q3 2018. 38 funds tracked by Wall St. Rank hold LRMR as of Q3 2020.

  • Private Advisor Group reported no remaining Larimar Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 121 Larimar Therapeutics shares in Q3 2020, an estimated $2K.
  • Private Advisor Group first reported a position in Larimar Therapeutics in Q1 2017 and held it in 8 quarters.
  • Private Advisor Group's Larimar Therapeutics position peaked at $205K in Q3 2018.
  • 38 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.